[an error occurred while processing this directive]
透析心理学

慢性肾脏病患者认知和抑郁障碍的评估及分析

  • 史嫣 ,
  • 刘东伟 ,
  • 乔颖进 ,
  • 郭佳 ,
  • 潘少康 ,
  • 刘章锁
展开
  • 1.1郑州大学第一附属医院肾脏病中心,郑州大学肾脏病研究所,河南省慢性肾脏病精准诊疗重点实验室,国家肾脏疾病临床医学研究中心核心单位

收稿日期: 2018-10-04

  修回日期: 2019-07-26

  网络出版日期: 2019-09-27

基金资助

国家重点研发项目(No.2016YFC1305404);科技惠民计划项目(Projiect No.162207310001)

Assessment and analysis of the cognitive and depressive disorders in chronic kidney disease patients

  • SHI Yan ,
  • LIU Dong-Wei ,
  • QIAO Ying-Jin ,
  • GUO Jia ,
  • PAN Shao-Kang ,
  • LIU Zhang-Suo
Expand
  •  1Department of Nephrology, the First Affiliated Hospital of Zhengzhou University; Institute of Nephrology Research, Zhengzhou
    University, Zhengzhou 450052, China

Received date: 2018-10-04

  Revised date: 2019-07-26

  Online published: 2019-09-27

摘要

【摘要】目的探讨慢性肾脏病患者认知和抑郁障碍的情况,分析其可能机制。方法根据受试者的肾小球滤过率将179 例受试者分成健康对照组:eGFR>90 ml/(min·1.73m2),肾小球滤过率轻度下降组:30<eGFR<60 ml/(min·1.73m2),肾小球滤过率重度下降组:eGFR<30 ml/(min·1.73m2)组。用简易精神状态检查表(mini-mental state examination,MMSE)和抑郁自测量表(self-rating depression scale,SDS)评估受试者认知功能和抑郁情况,对比分析其颅脑MRI 显影,统计腔隙性脑梗死和脑白质脱髓鞘发生率。结果肾小球滤过率轻度下降组和重度下降组的MMSE 量表评分分别为26.53±0.41(c2=3.046,P=0.003)、23.47±0.94(c2=6.000,P<0.001)和SDS 量表评分分别为39.18±1.55(c2=2.098,P=0.033)、45.6±1.93(c2=9.183,P=0.002), 与健康对照组相比差异有统计学意义;肾小球滤过率轻度下降组及重度下降组伴认知或抑郁障碍的患者腔隙性脑梗死和脑白质脱髓鞘的发生率分别为42.5%
(c2=4.482,P=0.034)、52.5% (c2=10.474,P=0.001)、50.0% (c2=4.842,P=0.028)、65.0% (c2=6.983,P=0.013),与无认知和抑郁障碍的患者相比发生率较高。结论慢性肾脏病患者出现认知和抑郁障碍的风险较高,可能与患者出现腔隙性脑梗死和脑白质脱髓鞘有关。

本文引用格式

史嫣 , 刘东伟 , 乔颖进 , 郭佳 , 潘少康 , 刘章锁 . 慢性肾脏病患者认知和抑郁障碍的评估及分析[J]. 中国血液净化, 2019 , 18(10) : 693 -696 . DOI: 10.3969/j.issn.1671-4091.2019.10.009

Abstract

【Abstract】Objective To investigate the occurrence and mechanisms of the cognitive and depressive disorders in patients with chronic kidney disease (CKD). Methods According to glomerular filtration rate (eGFR) of the subjects, a total of 179 subjects were divided into healthy control group (eGFR>90 ml/min/1.73m2), eGFR slight decrease group (30<eGFR <60 ml/min/1.73 m2), and eGFR significant decrease group (eGFR<30 ml/min/1.73 m2). The Mini- mental State Examination (MMSE) and Self- rating Depression Scale (SDS) were used to evaluate the cognitive function and mental state of CKD patients. Brain MRI images were analyzed to calculate the rate of lacunar infarction and white matter demyelination. Results In eGFR slight decrease group and eGFR significant decrease group, the MMSE scores were 26.53±0.41 (c2=3.046, P=0.003) and 23.47±0.94 (c2=6.000, P<0.000) respectively, and the SDS scores were 39.18±1.55 (c2=2.098, P=0.033) and 45.6±1.93 (c2=9.183, P=0.002), statistically different from the scores in control group. In the patients with cognitive and depressive disorders in eGFR slight decrease group and eGFR significant decrease group, the rates of lacunar infarction were 42.5% (c2=4.482, P=0.034) and 52.5% (c2=10.474, P=0.001) respectively, and the rates of white matter demyelination were 50.0% (c2=4.842, P=0.028) and 65.0% (c2=6.983, P=0.013) respectively, statistically higher than the rates in patients without cognitive or depressive disorders in the two groups. Conclusions The risks for cognitive impairment and depressive disorder were higher in CKD patients, possibly relating to the presence of lacunar infarction and white matter demyelination in these patients.

参考文献

[1]Seliger S L, Siscovick D S, Stehmanbreen C O, et al.Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study[J].Journal of the American Society of Nephrology, 2004, 15(7):1904-1904 [2]Bugnicourt J M, Godefroy O, Chillon J M, et al.Cognitive disorders and dementia in CKD: the neglected kidney-brain axis[J].Journal of the American Society of Nephrology Jasn, 2013, 24(3):353-363 [3]Zhang L1, Wang F, Wang L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey[J].The Lancet, 2012, 3;379(9818):815-22 [4] Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. .KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J].[J].Kidney Int, 2013,, Suppl( Suppl):1-150 [5]段晓宇, 江新梅.在痴呆筛查中的应用[J].中风与神经疾病杂志, 2002, 19(3):167-168 [6] 舒良..自评抑郁量表[J][J].中国心理卫生杂志,, 1999,, (增刊):((增刊):): 194-196. [7] Lavine H, Jost J T, Lodge M.Political cognition and its normative implications for the "democratic experiment": Theory, evidence, and controversy[J].[J].Mario Mikulincer,, 2015, 2015:págs.(2015:págs.):721-752 [8]Etgen T1, Sander D, Chonchol M, et al.Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study[J].Nephrol Dial Transplant, 2009, 24(10):3144-50 [9]Smith, Kerri.Mentalhealth: Aworldofdepression[J].Nature, 2014, 515(7526):181-181 [10]Murray CJ, Lopez A D.Alternative projections of mortality and disability by cause 19902020:Global burden of disease study[J].Lancet, 1997, 349(9064):1498-1504 [11]Kang H J, Kim S Y, Bae K Y, et al.Comorbidity of depression with physical disorders: research and clinical implications[J].Chonnam medical journal, 2015, 51(1):8-18 [12]Chiang H H, Livneh H, Yen M L, et al.Prevalence and correlates of depression among chronic kidney disease patients in Taiwan[J].BMC Nephrology, 2013, 14(1):78-78 [13] Harris S, Kurniawan M, Rasyid A, et al.Cerebral small vessel disease in Indonesia: Lacunar infarction study from Indonesian Stroke Registry 2012-2014[J]. [J].Sage Open Medicine, 2018, 6(6):6.-6 [14]Bj?rkman M P, Sorva A J, Tilvis R S.Does elevated parathyroid hormone concentration predict cognitive decline in older people?[J].Aging Clinical & Experimental Research, 2010, 22(2):164-169 [15]Xue L, Lou Y, Feng X, et al.Prevalence of chronic kidney disease and associated factors among the Chinese population in Taian,China[J].BMC Nephrology, 2014, 15(1):1-6 [16]Choi S T, Kim J S, Song J S.Elevated serum homocysteine levels were not correlated with serum uric acid levels,but with decreased renal function in gouty patients[J].Journal of Korean Medical Science, 2014, 29(6):788-92 [17]Shanahan C M, Crouthamel M H, Kapustin A, et al.Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate[J].Circulation Research, 2011, 109(6):697-711 [18]Shi Y, Wardlaw J M.Update on cerebral small vessel disease: a dynamic whole-brain disease[J].Stroke & Vascular Neurology, 2016, 1(3):83-92 [19]van Uden I W, Tuladhar A M, de Laat K F, et al.White Matter Integrity and Depressive Symptoms in Cerebral Small Vessel Disease: The RUN DMC Study[J].American Journal of Geriatric Psychiatry, 2015, 23(5):525-535 [20]Appelros P, Andersson A G.Changes in Mini Mental State Examination score after stroke: lacunar infarction predicts cognitive decline[J].European Journal of Neurology, 2010, 13(5):491-495 [21]Wu R H, Li Q, Tan Y, et al.Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors[J].Neurological Sciences, 2014, 35(10):1553-1559 [22]Ryan M, Ibrahim M, Parmar H A.Secondary Demyelination Disorders and Destruction of White Matter[J].Radiologic Clinics of North America, 2014, 52(2):337-354 [23] 仇敬丽, 荆文彬, 谭娜.脑白质脱髓鞘精神症状的治疗[J].[J].医学信息,, 2014,, (28):( (28):):200--200. [24]Sun H L, Lee J.Protection of the brain through supplementation with larch arabinogalactan in a rat model of vascular dementia[J].Nutrition Research & Practice, 2017, 11(5):381-387 [25]A.J. Lloyd ?,Grace J B,Jaros E,et alDepression in late life,cognitive decline and white matter pathology in two clinico-pathologically investigated cases[J].International Journal of Geriatric Psychiatry, 2001, 16(3):281-287 [26]Carmeli C, Donati A, Antille V, et al.Demyelination in mild cognitive impairment suggests progression path to Alzheimer's disease[J].Plos One, 2013, 8(8(8)):e72759-e72759
文章导航

/

[an error occurred while processing this directive]